AMANDA G. LEWIS
phone: 202-789-3960
fax: 202-789-1813
AMANDA LEWIS joins us from the Federal Trade Commission, where she worked as an attorney in the Bureau of Competition since 2012. While at the FTC, Ms. Lewis served for over two and a half years as a Counsel-Detailee to the Antitrust Subcommittee of the House Judiciary Committee. In this role, Ms. Lewis worked extensively on the House Subcommittee’s Investigation of Competition in Digital Markets, for which Ms. Lewis led the portion of the investigation related to Amazon.
Ms. Lewis was one of the primary authors of the Majority Staff Report and Recommendations and helped draft the bills currently making their way through Congress to rein in Big Tech. In addition, Ms. Lewis took the lead on health care for the Subcommittee, overseeing several hearings related to competition in the healthcare sector and a successful, bipartisan markup of four healthcare antitrust bills, resulting in all four bills being reported out of Committee on a unanimous, bipartisan basis and the enactment of two bills into law, including the CREATES Act and the Competitive Health Insurance Reform Act.
At the FTC, as an attorney in the Mergers IV division, Ms. Lewis worked on the Staples/Office Depot and Sysco/U.S. Foods litigation teams, as well as numerous other merger and conduct investigations.
Prior to the FTC, Ms. Lewis was an associate at Cravath, Swaine & Moore and a law clerk for Judge Lawrence McKenna of the Southern District of New York. She received her B.A. from New York University in 2002 and her J.D. from Columbia Law School in 2008.
Associations & Memberships
- Member, Policy Task Force, COSAL (2022-Present)
- Co-Chair, U.S. Comments and Policy Committee, Section of Antitrust Law, American Bar Association (2022-Present)
- Vice Chair, Health Care and Pharmaceuticals Committee, Section of Antitrust Law, American Bar Association (2017-2022)
- Member, Biden Health Policy Committee, Subcommittee on Cost Containment; voluntary role designated by the Biden for President Campaign (Summer 2020)
In The News
CGL attorneys join distinguished panelists at the American Economic Liberties Project Anti-Monopoly Summit
admin2023-05-26T16:04:21+00:00April 26th, 2023|
Amanda Lewis’ Senate testimony quoted in Politico
admin2023-03-20T18:08:46+00:00March 20th, 2023|
Amanda Lewis’ testimony from the Subcommittee on Competition Policy, Antitrust and Consumer Rights of the Senate Judiciary Committee.
admin2023-04-25T13:08:10+00:00March 7th, 2023|
Amanda Lewis testified before the Subcommittee on Competition Policy, Antitrust and Consumer Rights of the Senate Judiciary Committee.
admin2023-03-21T15:08:21+00:00March 7th, 2023|
CGL’s Amanda Lewis serves as co-founder and Director of U.S. Competition Policy for a new coalition called the Responsible Online Commerce Coalition (ROCC).
admin2023-03-21T15:08:35+00:00March 3rd, 2023|
GCR – Big Tech foe to leave Congress
Feb 2023
POLITICO – All Tomorrow’s Monopolies
Sept 2022
Press Release – Amanda Lewis Joins CGL
Sept 2022
Bloomberg – Amazon’s iRobot Deal Seen Facing Tough FTC Antitrust Review
Aug 2022
FTC Watch – People – Amanda Lewis Joins CGL
Jul. 2022
Digital Future Daily, Politico – Transitions highlighting Statement From Subcommittee Chair David Cicilline
Sept. 2021
Protocol.com – A tiny team of House staffers could change the future of Big Tech
Oct. 2020
Publications and Speaking Engagements
- Editor – Judging Big Tech, The Washington Center for Equitable Growth (Dec. 2022)
- The Federalist Society – Biden’s Antitrust Agenda: Mission Creep or Mission Achieved? (Jul. 2022)
- IPLeadership – LeadershIP DMA Virtual Event: EU DMA vs. US Legislative Proposals: Lessons and Path Forward (Jun. 2022)
- ABA Panel – From Investigation to Litigation – Practical Skills for Handling Pharma Matters and Beyond (Jun. 2022)
- ABA Antitrust in Healthcare Virtual Conference – Antitrust Legislation: New Powers for State and Federal Enforcers(Feb. 2021)
- NYIPLA Presidents’ Forum, States Rights: Should States Legislate Intellectual Property in the Pharmaceutical Sector? ( Dec. 2020)
- AAI Pharmaceutical Markets – Competition Roundtable American Antitrust Institute (Sept. 2019)
- Executive Editor, Health Care Chronicle, Section of Antitrust Law, American Bar Association (2014-2022)
EDUCATION
COLUMBIA UNIVERSITY SCHOOL OF LAW J.D., May 2008, Harlan Fiske Stone Scholar
NEW YORK UNIVERSITY B.A., summa cum laude, Sept. 2002, in Political Science and Latin American Studies
SUBSTANTIVE PRACTICE AREAS
Antitrust
Consumer Protection
Digital Markets
Health Care
Litigation
Government Affairs
Third-Party Merger and Non-Merger Antitrust Representation
BAR ADMISSIONS
New York
COURT ADMISSIONS
United States District Court for the Southern District of New York
Second Circuit Court of Appeals and S.D.N.Y.
United States Court of Appeals for the Second Circuit
Ms. Lewis was one of the primary authors of the Majority Staff Report and Recommendations and helped draft the bills currently making their way through Congress to rein in Big Tech. In addition, Ms. Lewis took the lead on health care for the Subcommittee, overseeing several hearings related to competition in the healthcare sector and a successful, bipartisan markup of four healthcare antitrust bills, resulting in all four bills being reported out of Committee on a unanimous, bipartisan basis and the enactment of two bills into law, including the CREATES Act and the Competitive Health Insurance Reform Act.
At the FTC, as an attorney in the Mergers IV division, Ms. Lewis worked on the Staples/Office Depot and Sysco/U.S. Foods litigation teams, as well as numerous other merger and conduct investigations.
Prior to the FTC, Ms. Lewis was an associate at Cravath, Swaine & Moore and a law clerk for Judge Lawrence McKenna of the Southern District of New York. She received her B.A. from New York University in 2002 and her J.D. from Columbia Law School in 2008.
Associations & Memberships
- Member, Policy Task Force, COSAL (2022-Present)
- Co-Chair, U.S. Comments and Policy Committee, Section of Antitrust Law, American Bar Association (2022-Present)
- Vice Chair, Health Care and Pharmaceuticals Committee, Section of Antitrust Law, American Bar Association (2017-2022)
- Member, Biden Health Policy Committee, Subcommittee on Cost Containment; voluntary role designated by the Biden for President Campaign (Summer 2020)
In The News
CGL attorneys join distinguished panelists at the American Economic Liberties Project Anti-Monopoly Summit
admin2023-05-26T16:04:21+00:00April 26th, 2023|
Amanda Lewis’ Senate testimony quoted in Politico
admin2023-03-20T18:08:46+00:00March 20th, 2023|
Amanda Lewis’ testimony from the Subcommittee on Competition Policy, Antitrust and Consumer Rights of the Senate Judiciary Committee.
admin2023-04-25T13:08:10+00:00March 7th, 2023|
Amanda Lewis testified before the Subcommittee on Competition Policy, Antitrust and Consumer Rights of the Senate Judiciary Committee.
admin2023-03-21T15:08:21+00:00March 7th, 2023|
CGL’s Amanda Lewis serves as co-founder and Director of U.S. Competition Policy for a new coalition called the Responsible Online Commerce Coalition (ROCC).
admin2023-03-21T15:08:35+00:00March 3rd, 2023|
GCR – Big Tech foe to leave Congress
Feb 2023
POLITICO – All Tomorrow’s Monopolies
Sept 2022
Press Release – Amanda Lewis Joins CGL
Sept 2022
Bloomberg – Amazon’s iRobot Deal Seen Facing Tough FTC Antitrust Review
Aug 2022
FTC Watch – People – Amanda Lewis Joins CGL
Jul. 2022
Digital Future Daily, Politico – Transitions highlighting Statement From Subcommittee Chair David Cicilline
Sept. 2021
Protocol.com – A tiny team of House staffers could change the future of Big Tech
Oct. 2020
Publications and Speaking Engagements
- Editor – Judging Big Tech, The Washington Center for Equitable Growth (Dec. 2022)
- The Federalist Society – Biden’s Antitrust Agenda: Mission Creep or Mission Achieved? (Jul. 2022)
- IPLeadership – LeadershIP DMA Virtual Event: EU DMA vs. US Legislative Proposals: Lessons and Path Forward (Jun. 2022)
- ABA Panel – From Investigation to Litigation – Practical Skills for Handling Pharma Matters and Beyond (Jun. 2022)
- ABA Antitrust in Healthcare Virtual Conference – Antitrust Legislation: New Powers for State and Federal Enforcers(Feb. 2021)
- NYIPLA Presidents’ Forum, States Rights: Should States Legislate Intellectual Property in the Pharmaceutical Sector? ( Dec. 2020)
- AAI Pharmaceutical Markets – Competition Roundtable American Antitrust Institute (Sept. 2019)
- Executive Editor, Health Care Chronicle, Section of Antitrust Law, American Bar Association (2014-2022)
LET’S WORK TOGETHER
CGL is currently engaged in dozens of cases from product defect class actions to antitrust litigation to civil rights advocacy.
If you feel we could represent you in any of our current cases or in a new case, we would love to hear from you.